source
- EU regulator backs Novo's hemophilia A preventive therapy and recommends seven additional drugsThe European Medicines Agency's human medicines committee issued a positive opinion on Novo's preventive treatment for hemophilia A, indicating it meets the agency's standards for further developme…
- Electra Therapeutics raises $350 million in Nasdaq IPO to fund commercial expansionElectra Therapeutics announced that it priced its initial public offering on the Nasdaq at $350 million, becoming the 21st biotech to go public in 2026. The Bay Area‑based company said the capital…